COO

+ Watchlist + Portfolio

The Cooper Companies, Inc.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $76.73
52-Week Range: $58.89 – $89.83
Market Cap: —
P/E (TTM): 64.54
EPS (TTM): 1.18
Dividend Yield: —

Advanced Metrics

Price/Book: 1.80
PEG Ratio: 0.73
Return on Equity: 2.85%
Return on Assets: 2.52%
Gross Margin: 65.55%
Operating Margin: -2.87%
Profit Margin: 5.57%
Current Ratio: 1.27
Debt/Equity: 0.33
Total Debt: $2.73B
Free Cash Flow: $424.28M
Revenue Growth: 7.90%
Earnings Growth: —
Enterprise Value: $17.55B

COO Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$3.31B	$3.59B	$3.90B	$4.09B
Cost of Revenue	$1.17B	$1.24B	$1.30B	$1.41B
Gross Profit	$2.14B	$2.36B	$2.60B	$2.68B
Research & Development	$110.30M	$137.40M	$155.10M	$172.20M
Selling, General & Admin	$1.34B	$1.50B	$1.53B	$1.63B
Operating Expenses	$1.63B	$1.82B	$1.89B	$2.00B
Operating Income	$507.60M	$533.10M	$705.70M	$682.90M
EBITDA	$878.70M	$885.90M	$1.07B	$1.04B
Pretax Income	$475.30M	$412.90M	$582.30M	$566.50M
Income Tax	$89.50M	$118.70M	$190.00M	$191.60M
Net Income	$385.80M	$294.20M	$392.30M	$374.90M
Diluted EPS	1.94	1.48	1.96	1.87
Diluted Shares	198.80M	199.20M	200.40M	200.00M

COO Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$138.20M	$120.80M	$107.60M	$110.60M
Receivables	$557.80M	$609.70M	$717.00M	$829.00M
Inventory	$628.70M	$735.60M	$802.70M	$846.00M
Current Assets	$1.53B	$1.70B	$1.95B	$2.11B
Total Assets	$11.49B	$11.66B	$12.32B	$12.39B
Current Liabilities	$1.28B	$969.00M	$1.02B	$1.11B
Long-Term Debt	$2.35B	$2.52B	$2.55B	$2.46B
Total Debt	$2.76B	$2.57B	$2.58B	$2.51B
Total Liabilities	$4.32B	$4.11B	$4.23B	$4.16B
Retained Earnings	$6.58B	$6.88B	$7.27B	$7.64B
Shareholders' Equity	$7.17B	$7.55B	$8.08B	$8.24B
Working Capital	$253.40M	$735.90M	$928.70M	$993.60M
Net Debt	$2.60B	$2.44B	$2.47B	$2.39B

COO Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	$692.40M	$607.50M	$709.30M	$796.10M
Capital Expenditure	-$242.00M	-$392.50M	-$421.20M	-$362.40M
Free Cash Flow	$450.40M	$215.00M	$288.10M	$433.70M
Depreciation & Amortisation	$346.10M	$367.70M	$375.10M	$377.40M
Stock-Based Compensation	$54.20M	$62.10M	$75.10M	$70.50M
Investing Cash Flow	-$1.83B	-$449.00M	-$764.60M	-$372.90M
Financing Cash Flow	$1.19B	-$173.90M	$39.20M	-$425.90M
Dividends Paid	-$3.00M	-$3.00M	$0.00	$0.00
Share Repurchases	-$78.50M	$0.00	$0.00	-$290.10M
Net Change in Cash	$54.90M	-$15.40M	-$16.10M	-$2.70M

COO Income statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$1.00B	$1.06B	$1.07B	$1.02B	$1.08B
Cost of Revenue	$323.20M	$368.30M	$414.30M	$328.90M	$346.10M
Gross Profit	$679.10M	$692.00M	$650.80M	$695.20M	$735.40M
Research & Development	$45.50M	$44.60M	$41.40M	$44.30M	$42.50M
Selling, General & Admin	$399.00M	$421.70M	$419.20M	$390.20M	$676.20M
Operating Expenses	$494.30M	$516.30M	$510.40M	$482.40M	$766.40M
Operating Income	$184.80M	$175.70M	$140.40M	$212.80M	-$31.00M
EBITDA	$261.30M	$272.70M	$239.60M	$310.10M	$67.90M
Pretax Income	$144.50M	$151.90M	$116.80M	$192.20M	-$48.40M
Income Tax	$56.80M	$53.60M	$32.20M	$61.40M	$29.50M
Net Income	$87.70M	$98.30M	$84.60M	$130.80M	-$77.90M
Diluted EPS	0.44	0.49	0.43	0.66	-0.40
Diluted Shares	200.70M	200.00M	198.10M	196.70M	195.00M

COO Balance Sheet statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	$116.20M	$124.90M	$110.60M	$124.90M	$138.80M
Receivables	$780.90M	$792.30M	$829.00M	$807.10M	$809.20M
Inventory	$880.30M	$881.00M	$846.00M	$876.40M	$896.40M
Current Assets	$2.13B	$2.14B	$2.11B	$2.13B	$2.30B
Total Assets	$12.41B	$12.38B	$12.39B	$12.42B	$12.48B
Current Liabilities	$1.01B	$1.01B	$1.11B	$1.60B	$1.80B
Long-Term Debt	$2.52B	$2.43B	$2.46B	$1.88B	$1.86B
Total Debt	$2.59B	$2.48B	$2.51B	$2.50B	$2.46B
Total Liabilities	$4.13B	$4.02B	$4.16B	$4.06B	$4.24B
Retained Earnings	$7.46B	$7.56B	$7.64B	$7.77B	$7.70B
Shareholders' Equity	$8.29B	$8.35B	$8.24B	$8.36B	$8.24B
Working Capital	$1.11B	$1.13B	$993.60M	$538.10M	$495.10M
Net Debt	$2.47B	$2.35B	$2.39B	$2.37B	$2.32B

COO Cash Flow statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	$96.20M	$261.40M	$247.90M	$260.90M	$182.80M
Capital Expenditure	-$78.10M	-$96.90M	-$98.00M	-$102.20M	-$86.40M
Free Cash Flow	$18.10M	$164.50M	$149.90M	$158.70M	$96.40M
Depreciation & Amortisation	$92.60M	$95.40M	$98.40M	$95.50M	$95.40M
Investing Cash Flow	-$79.20M	-$98.10M	-$98.80M	-$102.90M	-$90.00M
Financing Cash Flow	-$8.60M	-$156.30M	-$164.40M	-$147.90M	-$75.80M
Share Repurchases	-$40.60M	-$52.70M	-$196.80M	-$92.50M	-$15.50M
Net Change in Cash	$8.40M	$7.00M	-$15.30M	$10.10M	$17.00M

Market Snapshot

About

The Cooper Companies, Inc. is a global medical device company headquartered in San Ramon, California, operating through two business units: CooperVision and CooperSurgical. CooperVision develops and manufactures soft contact lenses for vision correction, including daily disposable, monthly, and specialty lenses for conditions like myopia management and astigmatism. CooperSurgical provides medical devices, fertility solutions, and genomic services for women's healthcare. The company serves customers in over 100 countries and is a leading provider in both the contact lens and women's health markets.